Browsing by Author "Siti Norlia Othman"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Early Viral Clearance Among Covid-19 Patients When Gargling With Povidone-iodine And Essential Oils: A Clinical Trial(Japan Health Sciences University, 2020) ;Nurul Azmawati Mohamed ;Nizam Baharom ;Wan Shahida Wan Sulaiman ;Zetti Zainol Rashid ;Wong Kon Ken ;Umi Kalsom Ali ;Siti Norlia Othman ;Muttaqillah Najihan Samat ;Najma Kori ;Petrick Periyasamy ;Nor Azizan Zakaria ;Agni Nhirmal Kumar Sugurmar ;Nur Ezzaty Mohammad Kazmin ;Cheong Xiong Khee ;Siti Mariyam SanimanIlina IsahakBackground: Gargling had been reported to have significant roles in the prevention and treatment of respiratory tract infections. The purpose of this study was to assess the ability of regular gargling to eliminate SARS-CoV-2 in the oropharynx and nasopharynx. Methodology: This pilot, open labeled, randomized, parallel study compared the effect of 30 seconds, 3 times/day gargling using 1% povidone-iodine (PVP-I), essential oils and tap water on SARS-CoV-2 viral clearance among COVID-19 patients in a tertiary hospital in Kuala Lumpur. Progress was monitored by day 4,6 and 12 PCR (Ct value), gargling and symptoms diary as well as clinical observations. Results: Five confirmed Stage 1 COVID-19 patients were recruited for each arm. The age range was from 22 to 56 years old. The majority were males. Two respondents had co-morbidities, which were asthma and obesity. Viral clearance was achieved at day 6 in 100%, 80%, 20% and 0% for 1% PVP-I, essential oils, tap water and control group respectively. Analysis of 1% PVP-I group versus control group showed significant p-value for comparison of PCR results on Day 4, Day 6 and Day 12. Conclusions: This preliminary study showed that gargling with 1% PVP-I and essential oils show great potential to be part of the treatment and management of Stage 1 COVID-19. Larger studies are required to ascertain the benefit of gargling for different stages of COVID-19 patients. This study was registered in clinicaltrial.gov (NCT04410159).